FibroGen, Inc. , a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
Fibrogen stock last closed at $5.75, up 11.43% from the previous day, and has decreased 79.09% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Fibrogen stock is currently +27.78% from its 52-week low of $4.50, and -84.97% from its 52-week high of $38.25.
As of Jun 20, 2025, there are 4.04M FGEN shares outstanding. The market value of FGEN is $23.24M. In the last 24 hours, 84,500 FGEN shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy FGEN shares.
In our opinion, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal info so you can invest in FGEN today.
Now that you have opened your account on the best stock trading app, you can securely and quickly fund your account:
Check out the video below if you need help transferring funds into your investment account.
After you have figured out the best place to buy Fibrogen stock, it's very important to evaluate their stock prior to investing, so you can comprehend the risk as well as the upside.
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on FGEN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge FGEN's true value.
You can access additional valuation research on FGEN's stock here.
Out of 1 Equities analysts who research FGEN, the consensus analyst rating on FGEN is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Fibrogen stock forecast page.
Over the past year, insiders at FGEN have bought more shares than they have sold.
Thane Wettig, CEO of FGEN, was the latest FGEN insider to buy. They bought $50,605.00 worth of FGEN shares on Mar 24, 2025.
Research more about who owns FGEN shares here.
No, Fibrogen doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
There are two main options:
Click the Open button and your broker will place the order.
If you need more help investing in stocks on eToro, watch the how to video below:
Now that you own some FGEN shares, you'll want to keep up with your company.
Make a watchlist to get alerted to the latest events about your FGEN stock.
To reiterate, here are the 6 steps you need to take to buy Fibrogen stock right now:
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Fibrogen, click the button below.